Status:
UNKNOWN
Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma
Lead Sponsor:
Children's Cancer and Leukaemia Group
Conditions:
Neuroblastoma
Eligibility:
All Genders
Up to 18 years
Phase:
NA
Brief Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors plan better treatment for patients receiving isotretinoin. PURPOSE: This clinical trial is studying t...
Detailed Description
OBJECTIVES: Primary * To investigate the feasibility of implementing individualized dosing of isotretinoin in patients with high-risk neuroblastoma after course 1 of treatment, based on isotretinoin...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Histologically confirmed high-risk neuroblastoma
- Concurrent isotretinoin as part of clinical treatment
- PATIENT CHARACTERISTICS:
- Not pregnant
- Fertile patients must use effective contraception
- Has a single- or double-lumen central venous catheter in place
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00939965
Start Date
February 1 2009
Last Update
August 12 2013
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Great Ormond Street Hospital for Children
London, England, United Kingdom, WC1N 3JH
2
University of Newcastle-Upon-Tyne Northern Institute for Cancer Research
Newcastle upon Tyne, England, United Kingdom, NE2 4HH
3
Royal Marsden - Surrey
Sutton, England, United Kingdom, SM2 5PT